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Abstract 
 
This paper investigates the influence of human resource management on learning from 
internal and external sources of knowledge. Learning for innovation is a key ingredient of 
catching-up processes. The analysis builds on survey data about pharmaceutical firms in 
Mexico. Results show that the influence of human resource management is contingent on the 
knowledge flows and innovation goals pursued by the firm. Practices such as training--
particularly from external partners; and remuneration for performance are conducive to 
learning for innovation. 
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1. Introduction 
 
Recent contributions to the literature suggests that differences in human resource management 
practices can explain diversity in innovation performances between firms, sectors of economic 
activity, even countries (Lorenz and Valeyre 2005; Lorenz and Wilkinson 2003; Michie and 
Sheehan 2003). Available studies indicate that such practices are complementary, to be used as 
part of coherent incentive systems (Laursen and Foss 2003). Consequently, empirical tests 
should consider the impacts of groups of practices rather than simply the effects of individual 
practices (Ichniowski et al. 1997). But why this is so? Consistent theoretical, empirical and 
comparative work on the linkages between human resource management and innovation is still 
at an early stage (Laursen and Foss 2003). Innovation scholars have thus joined the more ample 
debate of how and why human resource management influences a firm’s performance more 
generally (Boseli et al. 2005; Combs et al. 2006).  
 
The literature hints at some candidate factors linking human resource management to 
innovation. Arguably more careful exploration of the latent processes associated with the 
organization of people involved in innovation is needed.1 Based on Cohen and Levinthal (1990) 
and Wright et al. (2001) this paper looks at how human resource management contributes to 
learning and the development of innovation capabilities within an organization.  
 
Empirical work on human resource management and innovation stems mostly from surveys of 
firms in developed countries. By contrast, the case of developing countries remains largely 
uncharted; the omission is noteworthy. White (2002) argued that human resource management 
practices are a double edged sword for learning and innovation capacity building in developing 
countries. Such practices contribute to research and other technological capabilities at firm 
level; yet accumulated capacities can erode because of inadequate or poor management of 
people. Arundel et al. (2007) further contend that closer examinations of the relationship 
between human resource management, interactive learning and innovation should help to 
explain the conformation, functioning and development of national systems of innovation. This 
paper is one of the first systematic studies on human resource management and learning for 
innovation in a developing country context.  
 
Laursen and Foss (2003) and Datta et al. (2005) documented that the nature and corresponding 
influence of human resource management is contingent on the firm’s industry or sectoral 
affiliation; hence on the characteristics, challenges and opportunities associated to the 
innovation processes and knowledge bases in which a firm operates. Unfortunately detailed 
research about how those factors work remains scarce. This paper explores the case of the 
pharmaceutical industry. This is an industry that stands out at the global level for its 
socioeconomic, health and ethical implications; intensive R&D efforts characterize 
pharmaceuticals as a highly science-based industry. Pharmaceuticals are interesting from 
managerial perspective. Cockburn et al. (1999) asserted that changing technologies for drug 
discovery require changed practices to organize and motivate researchers; it demands strict 
                                                 
1 This intermediate approach is familiar for research on the influence of human resource management on 
creativity and creative thinking (Amabile 1996; Sternberg et al. 1997). 
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professional and balanced personnel and administrative management. Likewise Chiesa (1996) 
showed that differences exist in managerial approaches supporting drug discovery on the one 
hand, and drug development on the other. Since the latter type of activities is the more common 
in developing countries, usual conclusions about how human resource management influences 
learning and innovation can differ relative to studies about firms in developed countries.  
 
Laursen and Mahnke (2001) found positive relationships between firm types and knowledge 
strategies with combinations of human resource management practices in the context of 
innovation. Accordingly this paper identified some learning strategies followed by 
pharmaceutical firms in Mexico; it looked in particular, at those supporting learning from both 
internal and external sources of knowledge. The paper then enquired about which human 
resource management practices underpin the choice of joint learning strategies, and how this is 
done. This is one of the first studies in the field that incorporates external markets for 
knowledge as a relevant dimension for the analysis.  
 
The paper proceeds as follows: Section 2 discusses the literature on organizational learning and 
innovation with emphasis on catching up processes; reference to the pharmaceutical industry 
illustrates some of the main points. Section 3 introduces some specific human resource 
management practices supporting learning for innovation. The discussion informs some 
hypotheses to guide the subsequent empirical analysis. Section 4 presents the data and the 
research strategy used in this paper. Section 5 contains empirical results. Some final discussion 
and conclusions are presented in section 6.  
 
2. Literature review 
 
Knowledge creation within organizations is a complex cumulative, multilayered process. It 
begins at individual level, since employees are the building blocks of any organization (Nelson 
and Winter 1982). Simon (1991) suggests that organizations only learn through their members 
and/or by employing new members who add knowledge previously unavailable. The cognitive 
potential of organizations is, to a considerable extent, determined by accumulated skills and 
knowledge of their individual members (Nelson and Winter 1982). Good education is a key 
input, yet not sufficient to build an advanced level of individual knowledge. The more 
individuals advance in their areas of specialization the more the expertise they acquire and the 
larger their potential contribution to organizational knowledge.  
 
The importance of individual knowledge for organizational learning is further underscored by 
the fact that a significant part of the knowledge accumulated by individuals is tacit (Polanyi 
1966). Tacit knowledge refers to meaning acquired through experience and is difficult to 
formalize or communicate. It emerges during the actions and activities that individuals 
undertake and relates to the context in which these take place. Tacit knowledge is the “practical” 
foundation of individual skills (Nelson and Winter 1982). Nonaka (1994) and Nonaka and 
Takeuchi (1995) add that individuals’ intentionality or willingness to practice the search for 
meaning in their environment in order to understand and improve it, is critical to the 
enhancement of individual knowledge. In their view, intention and freedom are major forces 
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motivating individuals to expand their knowledge. Building working environments suitable for 
all the aforementioned processes to take place is imperative for firms.  
 
Zack (1999) and Kessler et al. (2000) point out that organizational learning involves choices 
regarding internal and external sources of knowledge; firms often need to decide whether to 
develop their own knowledge or acquire and/or imitate that of others. The main reason to 
develop knowledge internally is to generate absorptive capacity (Cohen and Levinthal 1990). 
Absorptive capacity refers to the ability to evaluate and use outside knowledge. It is based on the 
level of related knowledge already available in firms, including basic skills as well as recent 
technological and scientific developments in specific fields. Absorptive capacity arises out of 
previous knowledge accumulation and intensity of current learning efforts by firms and their 
members. External sources of knowledge, in turn, bring fresh thinking and provide a benchmark 
for internal efforts. Sources of external knowledge include other firms, but also external 
publications, universities, research institutes, government agencies, consultants and 
professional and personal networks. Kim (1997 and 1998) developed an international dimension 
to this argument by quoting that external knowledge acquisition and imitation can function 
across and connect national systems of innovation. 
 
Empirical literature documents that dynamic latecomer firms have coupled local searches, 
through internal learning efforts, with diffusion and assimilation of external knowledge through, 
for instance, reverse engineering. Learning strategies differ in complexity, uncertainty and risk, 
let alone the type of resources and how these are mobilized by firms in search of specific goals. 
In order to catch-up learning strategies have to be incorporated strategically over a sufficient 
time horizon as benefits take time to materialize. Short-time benefits from knowledge sharing 
cannot sustain long-term expansion strategies without the creation of internal knowledge and 
absorptive capacity to support the acquisition of external knowledge (Cardinal and Hatfield 
2000). Human resource management influences and plays a mediatory role in these processes; 
it influences the organization and mobilization of individuals and their corresponding 
knowledge (Barney 1991; Cohen and Levinthal 1990). Such systems assist in the creation, 
transfer and integration of knowledge flows that enrich a firms’ human capital, as a stock 
(Wright et al. 2001); in ways that are valuable, rare and inimitable (Grant 1996). Firms can 
guide systems of innovation by searching among, eventually nurturing the knowledge residing 
outside their physical boundaries. The pharmaceutical industry is illustrative of the issues 
discused above. 
 
Learning and catching-up in pharmaceuticals 
 
Kim et al. (1989) identified three main channels for pharmaceutical firms in developing 
countries to develop new products: (1) by developing new raw materials through in-house R&D; 
firms can substitute parts of the manufacturing process of patented drugs; (2) by relying on 
multinationals as source of technology through licensing or technical assistance; and (3) by 
purchasing active ingredients and excipients in open markets. In any of the two later cases, 
domestic R&D efforts are needed to build up the capacities required to manufacture the final 
drug.  
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As firms gain in technological complexity and innovation capacity, internal learning plays 
increasingly relevant roles moderating the process of learning from external markets (Escribano 
et al. 2009; Hung and Ruei-Hung 2008). In a study about the differences in technological 
strategies and corresponding innovation behaviours of 37 pharmaceutical firms in Korea, Kim et 
al. (1989) categorized firms according to scale of operations and technological capabilities. Large 
firms with significant technological capabilities used external knowledge to complement 
domestic technological efforts. They exhibited the highest degree of innovativeness. By contrast, 
large firms with relatively lower capabilities relied on external knowledge to improve short-term 
profitability. Finally, smaller firms showed a dual behaviour: On the one hand, firms that had 
developed some fair technological capabilities relied, almost exclusively, on domestic research 
efforts; they enjoyed the highest rates of growth. On the other hand, small firms with low 
capabilities tended to imitate products with relatively limited technological complexity. Mobility 
of personnel constituted their preferred channel to capture external knowledge.  
 
More recently Singh (2007) documented the progression in the innovative capacity of Indian 
drug manufacturers. Starting as bulk generic suppliers, Indian firms are gaining presence in 
drug discovery and clinical research. Notable for this process has been the formation of alliances 
with large US and European firms; efforts to capture and benefit from knowledge and 
experience of highly qualified Indian expatriates and significant export orientation (Meyers 
2006; Reddy 1997).  
 
In addition to some firm characteristics and environmental factors, the literature stresses the 
contribution of human resources for successful catching-up in the pharmaceutical industry. 
Such contribution has been linked to the availability of human resources, well defined corporate 
goals and managerial preferences. Equally important have been the promotion of good 
engineering and research skills, an aggressive entrepreneurial orientation, dynamic 
organizational practices and engineering leadership.  
 
In the case of pharmaceuticals in Mexico, Zúñiga et al. (2007) studied the joint use of in-house 
R&D and technology transfer over the period 1994-2000. The study concluded that internal and 
external learning strategies are exogenous in the local industry. In-house R&D has little 
influence on external acquisition of technology; at the same time, technology purchases only 
marginally affect corporate R&D investment decisions. The authors indicated that the observed 
low probability of complementarities could be explained by two divergent technological 
objectives of pharmaceutical firms. Market exposure, through exports for example, drives R&D. 
By contrast, external procurement of technology responds to searches for increased 
productivity, capital intensity and company size. Nevertheless international diversification, 
through exports, can lead to joint learning strategies.  
 
This paper re-examines some of the conclusions by Zúñiga and colleagues). In order to do so, it 
incorporates additional information about the learning processes taking place inside the firm. 
Major differences include our finer definitions of the dependent variables; Zúñiga and 
colleagues looked only at whether firms performed R&D or not, or the participation of 
pharmaceutical firms in technology licensing. Moreover, the inclusion of variables on human 
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resource management practices sheds light on how such interventions influence adoption of 
combined learning activities.  
 
3. Human resource management and learning  
 
This section identifies some human resource management practices conditioning individuals’ 
and, thereby, organizational learning. Relevant interventions include training, compensation for 
performance, worker’s participation in decision-making, rotation assignments and staff hiring.  
 
Training: Training supports development of technical skills but also managerial and 
interpersonal skills for planning, decision-making and organizational development. In addition 
to formal knowledge acquisition, training can include reflection on learning and learning 
through problem-solving (Gray et al. 2004). Training takes two main forms: on-the-job, 
frequently provided by staff attached to the organization and off-the-job, through formal 
external, classroom, education and linkages to external knowledge-producers (Okada 2004). 
Training helps to address motivational problems affecting blue-collar workers facing extremely 
low levels of education and limited development opportunities (García 2002). Frequent 
problems result from poor formalization of training structures, mismatches between training 
and promotion opportunities, enhanced independence, authority and responsibility (Samstad 
and Pipkin 2005). This is compounded by weak incentives for training, incompatibility with 
work schedules, inappropriate conditions for new skills to be put in place and high post-training 
turn-over (Abramo 1997). From the above, it is expected that: 
 
H1: Training influences positively the likelihood that a firm adopts joint learning strategies. 
 
Compensation: The type of compensation incentives and how they are administered to workers 
condition motivational styles and attitudes towards work (Florida and Goodnight 2005). The 
literature recommends the provision of a mix of intrinsic rewards-such as greater autonomy, 
additional developmental opportunities and public recognition; and extrinsic ones–such as pay 
increases and promotions (James 2002; Mumford 2000). Accordingly, in Mexico compensation 
packages usually include something more than nominal salaries. Non-pecuniary, ‘status 
enhancing’ perks are highly appreciated particularly at higher levels of responsibility and skills 
(Stephens and Greer 1995). Studies about the maquiladora industry in Mexico, characterized by 
high turn-over rates, indicate that compensation mechanisms are instrumental to attract, 
motivate and retain personnel (Dussel 2003; Stephens and Greer 1995). However in developing 
countries compensation for performance is often conditioned by tight markets for skilled-labour 
and wage contention policies, as means to keep inflation in check and underpin industrial 
competitiveness. The discussion above suggests that: 
 
H2: In general, remuneration levels positively influence adoption of joint learning strategies. 
 
Worker’s empowerment: The provision of decision-making and problem-solving rights, 
together with relevant knowledge, tools and incentives, opens up possibilities to influence and 
participate in the design and operation of work environments, to adapt or respond to emerging 
challenges and opportunities for innovation (Mumford 2000). In this regard, literature points 
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out that, in general, labor relations in countries such as Mexico are highly hierarchical; power 
flows top-down, based on paternalism, links of trust and loyalty between workers and 
immediate supervisors (Carrillo and Ramírez 1997; García 2002). Delegation of responsibility is 
limited to particular tasks, often without decision-making authority and resistance to follow-up 
and control (Martínez and Dorfman 1998). However, difficulties for Mexican workers to assume 
higher responsibilities, to participate actively in organizational or technical change often stem 
from their low qualification and education attainment (Abramo 1997). Rao and Teegen (2001) 
argue that highly-skilled Mexican workers, notably those working for multinational affiliates or 
high-standard Mexican companies, are less inclined to traditional work styles. Particularly at 
managerial levels, Mexicans show strong work ethics and openness to long journeys and assume 
extraordinary responsibilities. The discussion so far suggests that: 
 
H3: In general, workers’ empowerment positively influences adoption of joint learning 
strategies by the firm. 
 
Rotation assignments: According to literature on Japanese organizational practices rotation 
assignments promote knowledge diffusion within firms. Rotation supports programme 
development and implementation, provide group interaction and minimize friction and conflict; 
it also enhances coordination across multiple tasks and understanding of problems faced by 
other colleagues (Jones 1996; Mumford 2000). This notwithstanding, in the context of Mexico 
and other Latin American countries rotation can have opposite effects on firms’ performance. 
For example, Abramo (1997) documented that, although widely diffused across industries in the 
region, rotation is seldom accompanied by wage increases, changes in the time supervisors 
established for more experienced workers to complete similar tasks or, well designed training 
and retention programmes. Rotation intensifies job responsibilities, work-related diseases and 
job dissatisfaction; potential benefits are frequently hindered by strict job descriptions and task 
specialization associated with assembly processes (García 2002). In light of this somewhat 
conflictive evidence: 
 
H4: Rotation assignments can influence positively the likelihood that firms perform dual 
learning strategies. 
 
Staff hiring: Strategic hiring, ways to introduce new members to the organization, in team 
building or in training programmes are all recognized as means for firms to accumulate 
technological and other types of capabilities. March (1991) identified turnover and staff 
replacement as mechanisms introducing variability in organizations and whereby, renewed 
opportunities for organizational learning. New comers reduce levels of socialization within the 
firm, relative to more experienced staff; in such a way firms can induce increased opportunities 
to exploration and knowledge accumulation. A mix of experience and skills, the intention to 
keep consistency with in-house innovation or production teams, with short- and long-term 
knowledge requirements constitute relevant criteria to hire new staff (Du and Ai 2008; 
Santamaría et al. 2009). Potential benefits from hiring new staff stem however, from the 
introduction of increased diversity in individual knowledge, rather than on an intrinsic 
superiority in the skills and knowledge of new employees. Staffing practices in Mexico are often 
constrained by whether firms seek for blue-collar or more skilled white-collar personnel. In the 
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first case the process is relatively simple given the traditionally low qualification of the local 
labour force. Things complicate when staffing positions requiring increasing skills, as the 
country lacks a critical mass of well trained and experienced people; finding the right candidate 
induces greater complications and larger costs (Forest 1994). The discussion so far leads to the 
expectation that: 
 
H5: Staff hiring supports acquisition of external knowledge to complement internal learning 
efforts. 
 
4. Data and research strategy 
 
Data used in this paper were extracted from the Encuesta Nacional de Empleo, Salarios, 
Tecnología y Capacitación (ENESTyC).2 This survey was carried out by the Instituto Nacional 
de Estadística, Geografía e Informática (INEGI) on behalf of the Secretaría del Trabajo y 
Previsión Social (STPS), Mexico. ENESTYC represents the entire Mexican manufacturing 
sector. The manufacturing establishment constitutes the unit of analysis. The survey builds on a 
stratified sample based on the establishment’s size, as measured by total employment: Large 
251+; medium: 101-250; small: 10-100 and micro: 0-5. Establishments with 100 or more 
employees are included together with a random sample of those with less than 100 employees. 
Confidence level is 95 percent, with an estimated non-response of 10 percent.  
 
The latest available publication of ENESTYC corresponds to 2001. Nevertheless, based on an 
agreement to comply with pertinent confidentiality requirements by INEGI, personnel from the 
Institute processed, on our behalf, the preliminary data for the event 2005. The information 
corresponds to the year 2004. In ENESTYC the module for the pharmaceutical industry (NASCI 
code 3254)3 includes 141 data points; however, the effective working sample, excluding missing 
values, is 112 data points. The remaining of this paper uses, indistinctly, the terms establishment 
and firm.  
 
Dependent variables: ENESTYC contains information on pharmaceutical R&D performed in 
Mexico; this is represented as rd_inhouse. The dataset equally identifies the objectives of R&D. 
In line with Mexico’s specialization in generic drugs, the novelty of the R&D outcomes takes the 
firm as reference; innovations can be new to the firm but not necessarily to the Mexican market 
or the world. This paper focuses on R&D supporting: improvement or design of new machinery 
and equipment for the firm’s own use; this is interpreted as new process innovation. 
Alternatively, R&D underpins the design of new pharmaceutical products. This paper looks at 
firms that perform R&D for new product/process innovation, as denoted by 
rd_new_proc_prod.4 The distinction of R&D in terms of both novelty and outcome is a step 
forward as compared with Zúñiga et al. (2007); they looked at R&D in generic form only. 
                                                 
2 ENESTYC stands for National Survey on Employment, Wages, Technology and Training in the 
manufacturing industry, Mexico.  
3 NASCI stands for North American Industrial Classification System. 
4 In the interest of space and feasibility of the analysis, the study of the relationship between human 
resource management and the indicators on R&D for product and process innovations, respectively, is the 
matter of a separate paper.  
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The variable on external learning (external_mkt), in turn, denotes that firms obtain technology 
from external markets by means of: purchase of technology packages, acquisition of machinery 
and equipment, hiring consultant firms, accessing specialized literature, technology licensing, 
and/or through collaboration with other firms in order to learn about the general conditions of 
the industry. A firm can also do R&D in partnership with other agents. Based on Cassiman and 
Veugelers (2006) a firm is considered an active learner if it pursues at least one of the former 
seven activities. Table 2 below provides further details on the dependent variables. 
 
Control variables: Arundel et al. (2007) in the case of Europe, OECD (1998) for the OECD 
countries and Kaplinsky (1995) for developing countries documented the interrelation between 
adoption of modern management practices and organizational strategies adopted by firms. Such 
strategies correspond with the type of management practices available for firms, and shape the 
environment in which learning takes place (Arundel et al. 2007). In the case of pharmaceutical 
firms, and in the context of Good Manufacturing Practices (GMPs),5 total-quality-management 
(TQM) and just-in-time (JIT) practices assist in meeting the strict quality controls required by 
regulatory authorities. In this study the variable modern_practice controls for the use of JIT 
and/or TQM.  
 
Capital origin and export behaviour condition strongly the technological performance of 
pharmaceutical firms in developing countries (Kim 1989; Zúñiga et al. 2007). Foreign 
ownership will determine the perceived importance of R&D for the firm’s business strategy in 
the host country. In the case of countries such as Mexico, multinational affiliates generaly show 
a rather passive technological behavior; R&D remains concentrated at the parent company. In 
the case of exports, systematic R&D efforts assist firms in meeting some of the challenges 
derived from increased exposure to foreign markets. This paper incorporates these observations 
via the variables fdi and export_dummy, respectively. Finally, the paper captured scale effects 
associated with a firm’s size, as defined in terms of total employment. 
 
Variables on human resource management: ENESTYC contains data on human resource 
management practices adopted by pharmaceutical firms in Mexico. The practices include the 
provision of training, the use of rotation assignments and worker’s participation in decision-
making; additional questions indicate the regulation of practices such as staff hiring and 
rotation. In general, variables are measured in terms of adoption by the firm. A few variables in 
the dataset reflect intensity of human resource management practices. For example, indicators 
on worker’s participation in decision-making and rotation show the importance of such 
practices from the perspective of the employer. Delery (1998) advised to explore the effects of 
distinct human resource management constructs on a firm’s performance; accordingly, this 
paper incorporated distinct definitions for each variable included in the analysis.  
 
Annex 1 presents detailed definitions and descriptive statistics for the control and explanatory 
variables used in this paper; the correlation analysis appears in Annex 2. 
 
                                                 
5 GMPs define the best rules/practices to manufacture a drug as approved by health authorities in a given 
country (Seiter 2005). 
13 
Research strategy  
 
The dependent variables in this paper are binary; they indicate the adoption of internal and 
external learning strategies, respectively. The expected interrelation among these two strategies 
suggests the presence of some unobservable characteristics of the firm that influence the 
selection of learning strategies. A suitable econometric approach for this study is bivariate probit 
analysis; as an extension of probit regression, the bivariate specification allows the running of 
two simultaneous equations with the expected correlation in the disturbance terms (Greene 
2003). The resulting system of equations looks as follows:  
 
yi* and yj* are latent variables, such that:  
yi*= In-house R&D  
yj*= Acquisition of external technology 
M = Vector of management variables that influence the probability of choosing among learning 
strategies  
X = Vector of firm characteristics (control variables) that influence the probability of choosing 
among learning strategies 
iε , iν = Vectors of disturbances  
iuiXMyi εβ ++= '* , Yinternal=1, if 0* >iy , 0 otherwise    (1) 
iujXMyj νδ ++= '* , Yexternal=1, if 0*>yj , 0 otherwise    (2) 
 
The approach assumes: 
0),/(),/( == xmExmE νε , 
1),/(),/( == xmVarxmVar νε , 
ρνε =),/,( xmCov  
 
Modeling proceeded as follows: first, a basic model was identified, including the dependent 
variables, rd_inhouse and external_mkt. Then, the rd_new_proc_prod was introduced in order 
to account for the goals of R&D. The next step was to explore the effects associated with each of 
the different definitions of the human resource management variables; the information set was 
changed by shifting one group of practices at a time while keeping as close as possible to the 
structure of the basic model. This exercise served the additional goal of checking for the 
robustness of the results. 
 
In order to corroborate the adequacy of the bivariate specification, estimates were contrasted 
with those from equivalent univariate probit equations. The value and statistical significance of 
the errors correlation term, ρ, for the bivariate models was also examined. A positive and 
significant test of ρ indicates that the learning strategies are interrelated; univariate models will 
capture only partial information and render biased results (Greene 2003). Estimates for models 
in section 5 confirmed that the bivariate specification was adequate. An additional set of models 
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explored the extent to which the dependent variables are explained by the variables on firm 
characteristics.6 
 
5. Empirical results 
 
Mexico ranks among the top ten pharmaceutical markets in the world and second in Latin 
America. It is an important manufacturing and export base for Latin America and, to a lesser 
extent, the United States, Europe and Asia. The country has real, albeit poorly exploited, 
abilities to imitate and generate innovative pharmaceutical products (Guzmán 2005). Mexico 
contributes to pharmaceutical innovation during manufacturing and product life-cycle support 
of existing drugs; innovations are incremental, in the shape of new formulations, improved 
processes and product quality enhancements (Secretaría de Salud 2005). The industry is 
characterized by strong labour specialization requirements and salaries higher than others in the 
country.  
 
Multinational affiliates dominate the more lucrative private market in Mexico. Affiliates 
manufacture and export finished products with quality and safety standards comparable to 
developed countries; yet production scales are much lower. By contrast, local firms focus on 
manufacturing of generic drugs and depend strongly on sales to the public health sector. There 
is however a clearly identified segment of dynamic domestic firms whose business strategies rest 
on systematic innovative efforts. As generics manufacturers, they have developed some basic 
research capabilities, particularly, by incorporating modern biotechnology techniques. Table 1 
presents some descriptive statistics about the pharmaceutical industry in Mexico. 
 
[Table 1 here] 
 
Learning behaviour 
 
Table 2 reveals that a large share of pharmaceutical firms in Mexico performed R&D in-house 
during 2004 (62.5 percent); the number of firms active in external markets for knowledge was 
similar (60.7 percent). Distribution of firms by specific source of external knowledge is fairly 
diversified; yet, specialized literature seems the most frequent mechanism: 33.0 percent. 
Internal and external learning strategies are positively and significantly, albeit weekly 
correlated: 0.47. 
 
[Table 2 here]  
 
Table 3 reveals a significant number of firms pursuing internal and external learning strategies, 
49.1 percent. About 13.4 percent choose internal only, while 11.6 percent choose an external only 
strategy. Some 25.9 percent of firms pursued neither of these strategies. Clustering among 
learning strategies implies that doing more of one increases the expected return on the other. 
 
                                                 
6 In the interest of space results from univariate models and for those including the control variables only 
were omitted from presentation. Results are consistent with those presented in this paper. 
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As for the relationship between joint learning strategies and some specific human resource 
management interventions, some findings for pharmaceutical firms in Mexico are as follows: 
Firms show great propensity to provide training to employees, frequently in the form of both 
internal and external training. By contrast, pharmaceutical firms show a limited inclination to 
allow worker participation in decision-making. Even in those occasions when workers have a 
voice, the practice is reported as having little importance for the company. In the case of 
rotation assignments, firms in our sample reported heterogeneous behaviour; they distributed 
almost equivalently between those that do not use staff rotation; and those for which the 
practice is used and is reported as relevant. Finally, firms showed a strong propensity to regulate 
staff hiring practices. 
 
[Table 3 here] 
 
Econometric results 
 
Table 4 presents the results from the bivariate probit analysis. Model (1) includes rd_inhouse as 
internal learning strategy; model (2) replaces rd_inhouse with rd_new_prod_proc. 
Identification of variables whose effects and statistical significance are exclusive for a specific 
kind of learning strategy is indicative of complementarity between such strategies (Piga and 
Vivarelli 2004; Cassiman and Veugelers 2006). This finding supports the notion that building 
adequate internal absorptive capacity is necessary to engage and, eventually, benefit from 
linkages with external knowledge producers.  
 
Table 4 reveals that the use of a more detailed definition of R&D helps to better appreciate the 
effects of the explanatory variables on learning. Estimates for individual variables show the 
positive and statistically significant effects of training and remuneration for performance, 
particularly for internal learning activities.  
 
Estimates in Table 4 support previous findings by Zúñiga et al. (2007) as well. Foreign 
ownership tends to negatively impact on both internal and external learning activities. By 
contrast, exposure to external competition, through exports, underpins R&D by pharmaceutical 
firms. Scale effects are also taken into account, as remuneration for performance is expressed in 
interaction with a variable on the size of the firm.  
 
[Table 4 here]  
 
Marginal effects: A complementary way to look at results in table 4 is by computing the 
marginal effects on specific outcomes associated with changes in a given explanatory variable 
(Long and Freese 2006). In line with the goals of this paper, a third column for each of the 
models (1) and (2) reports the probability that a firm pursues joint learning strategies. The 
estimates confirm that the provision of training and remunerations have positive effects on joint 
learning strategies underpinning new product and/or process innovations. As for rd_inhouse, it 
is confirmed that only the provision of training seems to matter for the learning efforts of a firm. 
The marginal effects associated with the variables on firm’s characteristics corroborate the 
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conclusions that export behavior and foreign ownership influence learning by pharmaceutical 
firms in Mexico.  
 
Alternative definitions of human resource management practices 
 
The following sections present estimates from models with alternative specifications of the 
human resource management variables in model (2). The exercise serves to explore further the 
importance of human resource management variables while shedding light on the robustness of 
previous results.  
 
Provision of training: Table 5 and 6 present models with alternative definitions of training. 
Based on Laursen and Foss (2003) and Michie and Sheehan (1999 and 2003), model (3) 
distinguished between internal and external provision of training. Model (4) includes an 
interaction term between the two types of training. Casas (2001) argued that, in Mexico, training 
is one of the most important reasons for firms to interact with other agents in the environment. 
The models in table 6 identified different training providers: public and private universities, 
other firms, institutions linked to local trade organizations, individual consultants and 
machinery suppliers.7  
 
According to tables 5 and 6 the effects of training on learning strategies by pharmaceutical firms 
in Mexico change depending on the knowledge flows involved. This is consistent with Laursen 
and Salter (2004) who contend that managerial choice matters in shaping the propensity of 
firms to draw from universities, or in this case, other external training partners. Interestingly, 
external training contributes more significantly to in-house R&D for new product/process 
innovation than the internal kind. Estimates in table 6 show that the models for traditional 
knowledge producers rendered very poor results; by contrast, relationships with individual 
consultants and local trade organizations provided more meaningful information. In general, 
the effects on learning associated with remuneration for performance are more evident via the 
computation of marginal effects. For the remaining variables on human resource management, 
these provided no meaningful information for the analysis. No major changes were found in 
relation to the variables on firm’s characteristics. 
 
[Table 5 here]  
 
[Table 6 here]  
 
Worker’s empowerment: Michie and Sheehan (1999 and 2003) and Laursen and Foss (2003) 
investigated the effect of labour relations on the probability of a firm being an innovator. The 
indicators included the existence of procedures to file grievances or frequency of strike actions; 
the evidence on the impact of these variables on innovation performance was inconclusive. 
Unionization is a relevant practice in Mexico; it has been mandatory under local labour 
                                                 
7 Although not presented here, results from models with rd_inhouse showed the importance of internal 
training for in-house R&D. Estimates for variables on the firm’s characteristics were consistent with those 
reported here. 
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regulations and heavily influential on worker-employer relationships. For instance, García 
(2002) argued that local managers often recognize unions as major obstacles to implementing 
organizational and technical change. Communication and negotiation between these parties are 
poor. In order to explore these issues, the analysis incorporated the presence of unions inside 
the firm, together with an interaction term between labour unions and worker’s empowerment--
Table 7.  
 
Estimates from the models in table 7 indicate that simply allowing workers to participate does 
not influence learning activities—model (5); neither does it the presence of a labour union per 
se—model (6). However, interactions with local labour unions, as a way to channel worker’s 
participation in decision-making, can facilitate learning for innovation—model (7).  
 
Results for the remaining human resource management variables indicate that the provision of 
training is highly significant particularly for in-house R&D. Marginal changes in remunerations 
equally underpin joint learning strategies. Firm characteristics confirm the effects observed in 
tables 4 and 5. 
 
[Table 7 here]  
 
Compensation practices: Table 8 reports results for alternative indicators on remuneration for 
performance. Model (8) presents a more limited definition of compensation, in the form of 
salaries and excluding benefits. In Mexico the concept of payment per-hour is seldom provided, 
even faces serious constraints under both local labor laws and customary union practices; 
setting monthly remunerations is the usual practice (Samstad and Pipkin 2005). Nevertheless, 
since the practice of hourly remuneration is customary elsewhere in the world, models (9) and 
(10) include hypothetical variables on compensation per hour. In the first case, it is the full 
remuneration package, comprising salary plus benefits and, in the second, only salaries. The 
variables, normalized through a logarithmic transformation, capture scale effects associated 
with a firm’s size. 
 
Table 8 reveals that marginal changes in avgwage_size have positive, yet small impacts on the 
adoption of joint learning strategies. By contrast, none of the other measures of compensation 
provided meaningful information at standard levels of confidence. The remaining explanatory 
and control variables behaved in a fashion similar to that observed in tables 4 through 7.  
 
[Table 8 here]  
 
Rotation assignments: Four alternative definitions of rotation practices were investigated. In 
table, model (8) indicates that the firm uses rotation assignments regardless of their 
importance. Models (10) through (12) denote that the firm regulates temporary staff rotation 
either through collective contracts, any other form of internal regulation, or both. The models 
are statistically significant at customary confidence levels. 
 
Table 9 reveals a lack of statistical significance of staff rotation practices in the context of joint 
learning strategies. By contrast, the provision of training and compensation for performance 
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continue to underpin learning strategies. In the latter case the effects are perceptible through 
computation of marginal effects. None of the remaining human resource management 
interventions rendered statistically significant information. As for the variables on a firm’s 
characteristics, whereas exports support internal learning efforts, foreign ownership inhibits the 
use of both internal and external sources of knowledge. Modern organizational practices, in 
turn, influence participation in external markets for technology. 
 
[Table 9 here]  
 
Staff hiring: As a final exercise, table 10 presents the results for models with alternative 
definitions of staff hiring practices. Models (13) and (14) indicate that the firm regulates staff 
hiring through either collective contracts or any other form of internal regulation. The new 
variables on staff hiring failed to meaningfully explain the adoption of joint learning strategies 
by pharmaceutical firms in Mexico. As for the rest of explanatory and control variables, the 
estimated effects remained consistent with those observed in previous sections. When the firm 
hires new staff based on internal regulations, compensation for performance turned out 
statistically significant and positive for learning from external markets.  
 
[Table 10 here]  
 
6. Discussion and conclusions 
 
This paper argued that understanding the factors linking human resource management to a 
firm’s innovation performance calls for improved approaches to research. The analysis explored 
which and how human resource management practices support efforts to tap internal and 
external knowledge sources during the innovation process. The main contention is that such 
practices can either potentiate or constrain the learning opportunities, sanctions and rewards 
for individuals involved in innovation activities inside the firm.  
 
Building on empirical evidence about pharmaceutical firms in Mexico, the paper found that a 
significant share of those firms implement combined learning strategies. In principle this 
finding is positive as successful catching-up frequently involves strategic use of internal and 
external knowledge sources. It is even more relevant if firms are, eventually, to contribute to 
further advancement of the technological complexity of the industry and overall economic 
environment.  
 
This paper supports the conclusion by Zúñiga et al. (2007) on the complementarity of learning 
strategies in the pharmaceutical industry in Mexico; moreover one could agree that such 
complementarity is rather weak. Nevertheless a note of caution is pertinent here, as ENESTYC 
lacks information about customary innovation output indicators--patents, share of sales of 
innovative products and so on. These data limitations prevented the performance of more direct 
analyses of complementarity. Although Zúñiga and colleagues failed to recognize it, their study 
faced similar problems. Athey and Stern (1998) and Cassiman and Veugelers (2006) showed, 
theoretically and empirically, that in order to draw stronger conclusions about the nature of 
complementarity between learning strategies more direct tests are needed. Those tests include 
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some kind of innovation output function, together with finer gradations of the dependent 
variables. Hence, it is possible to investigate the impact of the chosen learning strategy on actual 
innovation performance. These perceived limitations do not invalidate our findings as our 
understanding of innovation was more as a learning and capability building process than as 
concrete outcomes in terms of product or process (Li et al. 2008). 
 
This paper illustrated the complexity of doing research on human resource management 
practices and a firm’s performance. Such practices are heterogeneous, a number of 
technological, market-related, institutional and idiosyncratic factors condition the way firms 
organize personnel. In our case, the focus on the pharmaceutical industry saved the need to 
control for industry and market differences, as in more traditional studies across industries. It 
also made it feasible to centre the attention on the stages of pharmaceutical innovation in which 
countries such as Mexico are able to participate. Arguably, both the nature of human resource 
management practices and their associated effects change depending on the particular stages of 
the innovation process in which firms, even countries, operate. A major drawback resulted 
however from the relatively limited size of the pharmaceutical industry in Mexico. 
 
Heterogeneity in human resource management approaches also implies the need to look at a 
large number of variables, let alone the many possible interactions expected between them. This 
paper in particular documented the importance of two specific practices: the provision of 
training, particularly by external providers; and to a lesser extent, remuneration for 
performance. These findings are consistent with previous studies suggesting that in countries 
such as Mexico, training and adequate compensation can lead to improved performance of the 
labour force (Carrillo and Ramírez 1997; Dussel 2003). It is likely that whenever firms are 
characterized by limited R&D, technological progress necessarily requires interaction with 
other, more specialized and experienced agents in the system of innovation. Both external 
training and remunerations serve such goal.  
 
In regards to the provision of training, and contrary to expectations from the literature, 
traditional knowledge producers failed to explain learning by pharmaceutical firms in Mexico. 
These results correspond with well documented mismatches between academic institutions and 
firms. In the particular case of Mexico, Ruíz (2004) argued about the distinct orientation of 
firms and public universities. Interactions between these agents are often hindered by 
bureaucratic burdens, limited flexibility and inability of universities to respond to a firm’s 
training requirements, especially when training does not lead to obtaining academic degrees. In 
extreme cases, the mismatch reflects a low esteem, even reticence of public universities to design 
study programmes by contacting and gaining feedback from the productive sector (Ruíz 2004). 
Our analysis suggests that pharmaceutical firms tend to privilege interactions with organizations 
that are more closely related to the operation of the industry. 
 
The literature suggests that adequate remuneration for performance should positively induce 
learning. In the case of pharmaceutical firms in Mexico, our evidence supported this idea only 
partially. The positive effects associated with remuneration were perceptible mostly via the 
computation of marginal effects. Is it that, in themselves, salaries in the industry are inadequate 
to promote learning for innovation? Is it because intangible issues, such as prestige and 
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recognition, are more relevant as mechanisms to underpin performance? For instance, 
Terziovski and Morgan (2006) argued that, in industries such as biotechnology, performance-
linked rewards might not be as attractive and stimulating as compared to access to sophisticated 
scientific equipment and instruments enabling researchers to pursue their work and increase 
their intellectual capital. Traditionally low levels of R&D expenditures by the private sector in 
Mexico would support this conclusion, as research infrastructure is limited or rather poor. 
Unfortunately, lack of more detailed information in the ENESTYC dataset prevented further 
exploration of these ideas here.  
 
Additional questions remain for future analysis. In principle, we need to better understand the 
role of rotation assignments in the pharmaceutical industry in Mexico. However widely diffused 
among firms, the practice was seldom perceived as important by the firm. In a way, this lends 
some support to the comments by Abramo (1997) and García (2002) in section 3. Similar 
conclusions can be drawn in the case of staff hiring, the different definitions failed to provide 
meaningful information about the influence of the practice on the adoption of joint learning 
strategies. 
 
Worker’s participation in decision-making turned out to be infrequent or seldom important for 
pharmaceutical firms in Mexico. Consequently, the effects of such practice on learning were 
difficult to perceive econometrically. The finding should be taken with a grain of salt however, as 
it may simply reflect the nature of the operation of the pharmaceutical industry. Changes in the 
characteristics of pharmaceutical products are constrained by eventual needs to modify the 
manufacturing process; hence the risk that such process will require recertification and 
obtaining of a new marketing authorization. FDA (2004) stressed that strong standardization 
and regulation of drug manufacturing is a major factor constraining innovation opportunities in 
drug manufacturing. Similar logic may limit the scope of decision-making in the case of 
development of generic drugs. 
 
A brief note on estimates for the control variables is obliged, as firm’s characteristics accounted 
strongly for the explanatory power of the models in this paper. Foreign ownership systematically 
and negatively impacted on learning. This finding reflects the position that Mexico occupies in 
the business strategies of global pharmaceutical firms. Apart from the adaptation of products to 
the local market, systematic R&D performance falls short from the objectives of multinational 
affiliates.  
 
By contrast, as suggested by Arora et al. (2001), competition in external markets for 
pharmaceutical products was found to positively influence learning. From a policy perspective 
this suggests the pertinence of promoting exports as a way to encourage innovation by local 
firms. The literature shows that successful catching up in South East Asia frequently involved 
strong orientation towards export markets. 
 
Last but not least, adoption of modern organizational practices was found to be positive and 
statistically significant particularly for external learning strategies. In our view this reflects 
Mexico’s well reputed position as a modern manufacturing centre (Cimoli 2002).  
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Table 1: Summary statistics for the pharmaceutical industry in Mexico, 2004 
 
Num. of establishments 112 Mean SD1 Min Max 
Employment  438.3 498.7 1.1 3391.5 
Total sales2  626557.6 1152467 2394 6958020 
     Domestic sales 553691.3 966085.1 0.0 6334508 
     Share of exports  0.07 0.15 0.0 1.0 
Share of foreign capital  0.31 0.46 0.0 1.0 
Years in operation3 31.7 18.8 0 74 
Notes: 1. Standard Deviation. 2. Thousand Mexican pesos; 3. Difference between the year in which a firm started operations in 
current business and year of collection of the survey, 2004 
Source: Author 
 
Table 2. Definition and correlations among the variables shaping the learning strategies of pharmaceutical firms in Mexico  
 
 
Variable construction 
Firms without 
missing 
values (N=112) 
1 1.1 1.2 2 2.1 2.2 2.3 2.4 2.5 2.6 2.7 
1. rd_inhouse 1 if firms carry out R&D for new product and/or process in-house; 0 otherwise 70 (62.5%) 1           
1.1 Design new machinery & 
equipment  
1 if firms declare the goal of R&D in-house is to 
create new machinery & equipment for own 
use; 0 otherwise  
21 (18.8%) 0.37* 1  0.47*        
1.2 Design new products 1 if firms declare the goal of R&D in-house is to design new products 69 (61.6%) 0.98* 0.33* 1 0.34*        
2. external_mkt 
1 if firms acquire technology through at least 
one of the following forms of contact with 
external agents. 0 otherwise:  
68 (60.7%) 0.47*   1        
2.1 Technology packages 1 if firms acquire packaged technology. 0 
otherwise 30 (26.8%) 0.34*   0.49* 1       
2.2 Consultant 1 if firms hire consultants. 0 otherwise 28 (25.0%) 0.23   0.46* 0.68* 1      
2.3 Literature 1 if firms access specialized literature in their field; 0 otherwise 37 (33.0%) 0.43*   0.57* 0.35* 0.43* 1     
2.4 Knowledge acquisition 
1 if firms carry out, in collaboration with other 
firms in the industry, activities geared to learn 
about the business environment and other 
conditions of the industry; 0 otherwise 
9 (8.0%) 0.09   0.24 0.12 0.21 0.07 1    
2.5 Machinery acquisition 1 if firms acquire machinery and equipment; 0 
otherwise 15 (13.4%) 0.20   0.32* 0.30* 0.38* 0.17 0.37* 1   
2.6 External R&D 1 if firms carry out R&D in collaboration with 
external agents; 0 otherwise 29 (25.9%) 0.37*   0.48* 0.29* 0.22 0.19 0.35* 0.43* 1  
2.7 Licensing 1 if firms license technology; 0 otherwise 21 (18.8%) 0.14   0.39* 0.17 0.30* 0.10 0.11 0.28* 0.19 1 
Notes: *Different from zero at 1% level of significance; variables in bold fonts were created by the authors  
Source: Author 
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Table 3 Frequency of choice of learning strategy by pharmaceutical firms in Mexico 
 External sources 
Internal sources No Yes Total 
No 29 (25.9) 13 (11.6) 42 (37.5) 
Yes 15 (13.4) 55 (49.1) 70 (62.5) 
Total 44 (39.3) 68 (60.7) 112 (100.0) 
 N=112 Pearson X2(1) = 24.9554*** 
Notes: Categories are exclusive; ***significant at 1 percent level of confidence; percentage 
share of each cell relative to the sample total in parentheses  
Source: Author 
 
 
 
Table 4: Bivariate models linking human resource management practices to learning strategies 
 
(1)  (2)  
Variables 
rd_inhouse external_
mkt 
MgEffect rd_new_pr
od_proc 
external_m
kt 
MgEffect 
train04 1.33*** 0.47 0.33*** 1.19** 0.48 0,34*** 
 (0.39) (0.40) (0.12) (0.46) (0.39) (0,11) 
rem_size 0.06 0.09* 0.03* 0.11** 0.09* 0,04** 
 (0.06) (0.05) (0.02) (0.06) (0.05) (0,02) 
rule_hiring 0.05 0.39 0.12 -0.25 0.37 0,03 
 (0.30) (0.26) (0.10) (0.30) (0.27) (0,10) 
imp_empowerment -0.18 0.14 0.03 -0.12 0.15 0,01 
 (0.24) (0.23) (0.09) (0.24) (0.24) (0,09) 
use_rotation_import 0.013 0.23 0.07 0.21 0.24 0,10 
 (0.19) (0.19) (0.07) (0.19) (0.20) (0,07) 
modern_practice 0.27 0.71** 0.25* 0.20 0.73** 0,21* 
 (0.38) (0.36) (0.13) (0.34) (0.36) (0,13) 
export_dummy 0.72** 0.50 0.22** 1.02*** 0.51 0,31*** 
 (0.35) (0.31) (0.11) (0.35) (0.31) (0,10) 
fdi -1.02** -1.29*** -0.47*** -1.51*** -1.31*** 
-0,53*** 
 (0.41) (0.34) (0.10) (0.44) (0.34) (0,09) 
Constant -1.02** -1.51***  -1.63*** -1.53***  
 (0.44) (0.51)  (0.55) (0.50)  
Observations   112    
Log Likelihood Full -103.7  -112.6  
Wald test full model [16]60.6***  [16]61.5***  
ρ 0.85 (0.09)  0.65 (0.12)  
Wald Test for ρ=0 [1]19.44***  [1]15.03***  
Notes: Robust standard errors in parentheses. ***, **, * denote significance at the 1%, 5% and 10% levels, respectively; 
degrees of freedom for X2 test in square brackets; Mg. Effect. Marginal effects.  
Source: Author. 
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Table 5: Bivariate probit models with alternative definitions of training 
 (3)  (4)   
Variables 
rd_new_p
rod_proc 
external_
mkt 
Mg.Effect rd_new_p
rod_proc 
external_
mkt 
Mg.Effect 
training_internal 0.34 0.052 0,08    
 (0.35) (0.35) (0,13)    
external_training  0.78** 0.38 0,24**    
 (0.33) (0.32) (0,12)    
internal_external_tr    0.38*** 0.16 0.11*** 
   
 (0.13) (0.12) (0.04) 
rem_size 0.07 0.08 0,03 0.07 0.08 0.03 
 (0.06) (0.06) (0,02) (0.06) (0.05) (0.02) 
rule_hiring -0.20 0.40 0,05 -0.21 0.39 0.05 
 (0.29) (0.27) (0,10) (0.29) (0.27) (0.10) 
imp_empowerment -0.10 0.16 0,02 -0.11 0.16 0.02 
 (0.24) (0.24) (0,09) (0.24) (0.24) (0.09) 
use_rotation_import 0.20 0.23 0,09 0.20 0.23 0.09 
 (0.19) (0.20) (0,07) (0.19) (0.20) (0.07) 
modern_practice 0.23 0.76** 0,22* 0.23 0.75** 0.22* 
 (0.35) (0.36) (0,13) (0.35) (0.36) (0.13) 
export_dummy 1.02*** 0.50 0,31*** 1.02*** 0.49 0.30*** 
 (0.33) (0.31) (0,10) (0.33) (0.31) (0.10) 
Fdi -1.41*** -1.25*** -0,51*** -1.42*** -1.26*** -0.51*** 
 (0.42) (0.35) (0,10) (0.41) (0.34) (0.09) 
Constant -1.22*** -1.35***  -1.23*** -1.38***  
 (0.44) (0.45)  (0.43) (0.44)  
Observations   112    
Log Likelihood Full -112.0  -112.1  
Wald test full model [18]72.36***  [16]72.01***  
ρ 0.65(0.12)  0.65(0.12)  
Wald Test for ρ=0 (1)14.6272***  (1)14.6349***  
Notes: Robust standard errors in parentheses; ***, **, * denote significance at the 1%, 5% and 10% levels, 
respectively; degrees of freedom for X2 test in square brackets; Mg.Effect: Marginal effects.  
Source: Author. 
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Table 6: Bivariate probit models for learning strategies underpinning new product and/or process innovation; by type of external training provider 
Variables Internal external Internal external Internal external Internal external Internal external Internal external Internal external 
training_internal 0.49 0.17 0.43 -0.02 0.53 0.15 0.57 0.16 0.51 0.18 0.57 0.12 0.51 0.10 
 (0.35) (0.34) (0.35) (0.35) (0.35) (0.34) (0.36) (0.34) (0.35) (0.35) (0.37) (0.38) (0.35) (0.32) 
training_firm 0.30 -0.02             
 (0.28) (0.29)             
training_freelance   0.58** 0.66**           
   (0.28) (0.29)           
training_priuniv     0.39 0.08         
     (0.34) (0.37)         
training_pubuniv       0.74 0.56       
       (0.46) (0.42)       
training_pubcent         0.26 -0.17     
         (0.36) (0.37)     
training_sup_mach           -0.03 0.06   
           (0.29) (0.31)   
training_tradeorg             1.51*** 0.58* 
             (0.45) (0.32) 
rem_size 0.09 0.09 0.11* 0.10* 0.09 0.09 0.11* 0.09* 0.10* 0.10* 0.10* 0.09* 0.08 0.08 
 (0.06) (0.06) (0.06 (0.05) (0.06) (0.06) (0.06) (0.06) (0.06) (0.05) (0.06) (0.05) (0.06) (0.05) 
rule_hiring -0.19 0.38 -0.34 0.27 -0.24 0.39 -0.26 0.36 -0.22 0.40 -0.21 0.40 0.090 0.55* 
 (0.28) (0.27) (0.29) (0.27) (0.28) (0.27) (0.28) (0.27) (0.28) (0.27) (0.28) (0.27) (0.31) (0.29) 
imp_empowerment  -0.11 0.16 -0.12 0.14 -0.12 0.16 -0.13 0.14 -0.10 0.17 -0.10 0.16 -0.14 0.16 
 (0.24) (0.24) (0.24) (0.24) (0.24) (0.24) (0.25) (0.25) (0.24) (0.24) (0.24) (0.24) (0.25) (0.24) 
use_rotation_import 0.21 0.24 0.18 0.20 0.22 0.24 0.28 0.28 0.22 0.25 0.22 0.24 0.16 0.20 
 (0.19) (0.20) (0.19) (0.20) (0.19) (0.20) (0.21) (0.20) (0.19) (0.20) (0.19) (0.20) (0.20) (0.20) 
modern_practice 0.29 0.76** 0.31 0.84** 0.30 0.77** 0.29 0.78** 0.27 0.77** 0.29 0.77** 0.24 0.76** 
 (0.34) (0.35) (0.34) (0.36) (0.33) (0.36) (0.34) (0.35) (0.33) (0.36) (0.34) (0.36) (0.36) (0.36) 
export_dummy 0.95*** 0.49 0.87** 0.36 0.91*** 0.48 0.89** 0.42 0.94*** 0.50 0.94*** 0.49 0.92** 0.46 
 (0.34) (0.31) (0.34) (0.32) (0.34) (0.33) (0.35) (0.32) (0.34) (0.32) (0.35) (0.32) (0.38) (0.31) 
Fdi -1.42*** -1.28*** -1.45*** -1.32*** -1.42*** -1.28*** -1.49*** -1.32*** -1.38*** -1.31*** -1.42*** -1.28*** -1.46*** -1.24*** 
 (0.42) (0.35) (0.41) (0.36) (0.43) (0.35) (0.45) (0.36) (0.43) (0.36) (0.45) (0.36) (0.47) (0.35) 
Constant -1.11** -1.25*** -1.08** -1.34*** -0.94** -1.24*** -1.11** -1.31*** -0.99** -1.29*** -1.04** -1.26*** -1.11** -1.28*** 
 (0.43) (0.44) (0.44) (0.45) (0.44) (0.45) (0.44) (0.45) (0.43) (0.45) (0.43) (0.44) (0.43) (0.44) 
Log Likelihood Full  -115  -113  -115  -115  -116  -116  -108 
Χ2  [16]53.2***  [16]59.6***  [16]52.9***  [16]52.1***  [16]52.6***  [16]51.5***  [16]59.3*** 
ρ  0.66  0.64  0.67  0.66  0.17  0.67  0.65 
Wald test, ρ=0  [1]15.99***  [1]14.61***  [1]16.58***  [1]15.47***  [1]16.69***  [1]16.14***  [1]13.94*** 
Notes: Observations: 112; Internal: rd_new_proc_prod; External: external_mkt; ***,**,* significant at the 1%, 5% and 10% confidence level; robust standard errors in parentheses; degrees of freedom for X2 test within squared 
brackets.  
Source: Author.   
29 
 
Table 7: Bivariate probit models with alternative definitions of worker’s empowerment 
 
 (5)   (6)   (7)  
Variables rd_new_prod_proc external_mkt Mg.Effects rd_new_prod_proc external_mkt Mg.Effects rd_new_prod_proc external_mkt Mg.Effects 
train04 1.20*** 0.49 0.35*** 1.14** 0.52 0.34*** 1.13** 0.41 0.33*** 
 
(0.46) (0.40) (0.11) (0.48) (0.39) (0.12) (0.44) (0.40) (0.11) 
rem_size 0.10* 0.09* 0.04** 0.11* 0.10* 0.04** 0.10* 0.09* 0.04** 
 
(0.06) (0.05) (0.02) (0.06) (0.05) (0.02) (0.06) (0.05) (0.02) 
rule_hiring -0.20 0.40 0.05 -0.23 0.35 0.03 -0.18 0.42 0.06 
 
(0.29) (0.27) (0.10) (0.28) (0.27) (0.10) (0.29) (0.27) (0.10) 
use_empow
er 
0.33 0.50 0.18       
 
(0.36) (0.37) (0.13)       
lab_union    0.13 -0.09 0.01    
 
   (0.32) (0.33) (0.11)    
pow_union       0.70* 0.75* 0.29** 
 
      (0.39) (0.39) (0.11) 
use_rotation
_import 
0.07 0.15 0.05 0.16 0.29* 0.10* 0.00 0.13 0.03 
 
(0.20) (0.20) (0.08) (0.17) (0.18) (0.06) (0.19) (0.20) (0.07) 
modern_pra
ctice 
0.10 0.67* 0.18 0.19 0.76** 0.22* 0.14 0.75** 0.21* 
 
(0.34) (0.36) (0.13) (0.33) (0.35) (0.12) (0.34) (0.36) (0.12) 
export_dum
my 
1.02*** 0.52 0.31*** 1.01*** 0.51 0.31*** 1.06*** 0.53 0.32*** 
 
(0.35) (0.31) (0.10) (0.35) (0.31) (0.10) (0.35) (0.32) (0.10) 
fdi -1.53*** -1.34*** -0.54*** -1.52*** -1.29*** -0.53*** -1.65*** -1.43*** -0.57*** 
 
(0.43) (0.34) (0.09) (0.42) (0.35) (0.09) (0.40) (0.37) (0.08) 
Constant -1.58*** -1.54***  -1.64*** -1.52***  -1.50*** -1.45***  
 
(0.54) (0.50)  (0.52) (0.53)  (0.53) (0.50)  
Obervs.     112     
Log 
Likelihood 
Full 
-112.1  -112.9  -110.8  
Wald test 
full model 
(16)61.6***  (16)63.1***  (16)66.7***  
ρ 0.63  0.64  0.62  
Wald Test 
for ρ=0 
(1)14.3790***  (1)14.8605***  (1)13.4196***  
Notes: Robust standard errors in parentheses; ***, **, * denote significance at the 1%, 5% and 10% levels, respectively; degrees of freedom for X2 test in square brackets; Mg.Effect: 
Marginal effects.  
Source: Author 
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Table 8: Bivariate probit models with alternative definitions of compensation for performance 
  (8)   (9)   (10)  
Variables rd_new_prod
_proc 
external_mkt Mg.Effects rd_new_prod
_proc 
external_mkt Mg.Effects rd_new_prod_pro
c 
external_mkt Mg.Effects 
train04 1.20*** 0.49 0.35*** 1.14*** 0.42 0.33*** 1.15*** 0.45 0.33*** 
 (0.46) (0.39) (0.11) (0.44) (0.38) (0.11) (0.43) (0.38) (0.11) 
avgwage_size 0.12* 0.09* 0.04**       
 (0.06) (0.06) (0.02)       
remhour_size    0.15 0.17* 0.07*    
    (0.10) (0.10) (0.04)    
wagehour_size       0.14 0.16 0.06 
       (0.11) (0.10) (0.04) 
rule_hiring -0.25 0.38 0.03 -0.16 0.45* 0.07 -0.15 0.45* 0.07 
 (0.30) (0.27) (0.10) (0.29) (0.26) (0.10) (0.29) (0.26) (0.10) 
imp_empowerment -0.12 0.15 0.01 -0.031 0.22 0.04 -0.029 0.22 0.04 
 (0.24) (0.24) (0.09) (0.23) (0.24) (0.09) (0.23) (0.24) (0.09) 
use_rotation_import 0.21 0.23 0.09 0.14 0.19 0.07 0.14 0.19 0.07 
 (0.19) (0.20) (0.07) (0.18) (0.20) (0.07) (0.18) (0.20) (0.07) 
modern_practice 0.20 0.72** 0.21* 0.21 0.75** 0.22* 0.20 0.73** 0.21 
 (0.34) (0.36) (0.13) (0.35) (0.37) (0.13) (0.35) (0.37) (0.13) 
export_dummy 1.01*** 0.50 0.31*** 1.04*** 0.49 0.31*** 1.04*** 0.49 0.31*** 
 (0.35) (0.31) (0.10) (0.36) (0.32) (0.11) (0.36) (0.32) (0.11) 
Fdi -1.51*** -1.30*** -0.53*** -1.41*** -1.29*** -0.51*** -1.38*** -1.25*** -0.50*** 
 (0.43) (0.34) (0.09) (0.42) (0.35) (0.10) (0.41) (0.35) (0.10) 
Constant -1.60*** -1.49***  -1.17*** -1.20***  -1.11*** -1.13***  
 (0.54) (0.50)  (0.42) (0.42)  (0.41) (0.41)  
Observations    112      
Log Likelihood Full -113  -113  -113  
Wald test full model (16)61.2***  (16)58.1***  (16)56.5***  
ρ 0.65  0.65  0.65  
Wald Test for ρ=0 (1)15.1403***  (1)15.0337***  (1)15.3094***  
Notes: Robust standard errors in parentheses; ***, **, * denote significance at the 1%, 5% and 10% levels, respectively; degrees of freedom for X2 test in square brackets; Mg.Effect: Marginal 
effects.  
Source: Author 
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Table 9: Bivariate models with alternative definitions of rotation assignments 
  (11)   (12)   (13)   (14)  
Variables rd_new_pr
od_proc 
External
_mkt 
Mg.Effec
ts 
rd_new_pro
d_proc 
External_mk
t 
Mg.Effects rd_new_pro
d_proc 
External_mk
t 
Mg.Effects rd_new_prod_
proc 
External_mkt Mg.Effects 
train04 1.17** 0.46 0.34*** 1.21*** 0.36 0.34*** 1.18*** 0.48 0.34*** 1.28*** 0.34 0.35*** 
 (0.46) (0.39) (0.11) (0.44) (0.37) (0.12) (0.44) (0.38) (0.11) (0.41) (0.39) (0.11) 
rem_size 0.11** 0.09* 0.04** 0.10* 0.09 0.04** 0.10* 0.08 0.04** 0.09* 0.10* 0.04** 
 (0.06) (0.05) (0.02) (0.06) (0.05) (0.02) (0.06) (0.05) (0.02) (0.06) (0.05) (0.02) 
rule_hiring -0.23 0.40 0.04 -0.18 0.35 0.04 -0.20 0.41 0.05 -0.027 0.20 0.04 
 (0.29) (0.27) (0.10) (0.29) (0.27) (0.10) (0.34) (0.30) (0.11) (0.33) (0.31) (0.11) 
use_rotation 0.37 0.36 0.02          
 (0.34) (0.36) (0.09)          
temp_rot_cc    -0.15 0.63* 0.06       
    (0.34) (0.38) (0.09)       
temp_rot_ir       0.005 0.01 0.07    
       (0.33) (0.34) (0.08)    
rule_temprotation          -0.34 0.42 0.06 
          (0.32) (0.33) (0.09) 
imp_empowerment -0.10 0.18 0.15 0.03 0.23 0.07 0.002 0.29 0.00 0.07 0.20 0.03 
 (0.24) (0.24) (0.13) (0.22) (0.23) (0.13) (0.22) (0.21) (0.12) (0.23) (0.23) (0.11) 
modern_practice 0.20 0.75** 0.22* 0.30 1.02*** 0.30** 0.33 0.86*** 0.26** 0.31 0.95*** 0.28** 
 (0.34) (0.36) (0.13) (0.35) (0.35) (0.12) (0.33) (0.33) (0.11) (0.34) (0.33) (0.11) 
export_dummy 1.02*** 0.50 0.31*** 1.00*** 0.50 0.30*** 0.99*** 0.48 0.30*** 1.04*** 0.50 0.31*** 
 (0.36) (0.31) (0.10) (0.36) (0.32) (0.11) (0.35) (0.31) (0.10) (0.35) (0.30) (0.10) 
fdi -1.50*** -1.29*** -0.53*** -1.45*** -1.33*** -0.53*** -1.45*** -1.24*** -0.51*** -1.48*** -1.30*** -0.52*** 
 (0.43) (0.34) (0.09) (0.43) (0.34) (0.09) (0.42) (0.34) (0.09) (0.42) (0.33) (0.09) 
Constant -1.62*** -1.51***  -1.57*** -1.50***  -1.56*** -1.47***  -1.53*** -1.54***  
 (0.54) (0.50)  (0.52) (0.50)  (0.55) (0.49)  (0.51) (0.49)  
Observations             
Log Likelihood Full -112.7  -111.4  -113.5  -111.2  
Wald test full 
model 
(16)62.4***  (16)65.7***  (16)61.6***  (16)76.4***  
ρ 0.64  0.69  0.65  0.70  
Wald Test for ρ=0 (1)15.0830***  (1)16.4549***  (1)15.7068***  (1)17.0065***  
Notes: Robust standard errors in parentheses; ***, **, * denote significance at the 1%, 5% and 10% levels, respectively; degrees of freedom for X2 test in square brackets; Mg.Effect: Marginal effects.  
Source: Author 
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Table 10: Bivariate probit models with alternative definitions of staff hiring 
 (15)  (16)   
Variables 
rd_new_prod_
proc 
external_
mkt 
Mg.Effec
ts 
rd_new_prod
_proc 
external_
mkt 
Mg.Effect
s 
train04 1.16*** 0.54 0,34*** 1.25*** 0.43 0,35*** 
 
(0.44) (0.39) (0,10) (0.43) (0.40) (0,11) 
rem_size 0.10* 0.10* 0,04** 0.11* 0.11** 0,04** 
 
(0.06) (0.05) (0,02) (0.06) (0.05) (0,02) 
hire_permwork_cc 0.05 0.05 0,02    
 
(0.34) (0.32) (0,11)    
hire_permwork_ir    -0.32 0.33 0,00 
 
   (0.30) (0.31) (0,11) 
imp_empowerment -0.08 0.09 0,00 -0.15 0.15 0,01 
 
(0.23) (0.25) (0,09) (0.24) (0.25) (0,09) 
use_rotation_import 0.18 0.26 0,10 0.21 0.24 0,10 
 
(0.18) (0.20) (0,07) (0.19) (0.20) (0,07) 
modern_practice 0.17 0.76** 0,21* 0.21 0.75** 0,22* 
 
(0.33) (0.35) (0,12) (0.34) (0.35) (0,12) 
export_dummy 0.99*** 0.51 0,30*** 1.05*** 0.48 0,31*** 
 
(0.35) (0.31) (0,10) (0.35) (0.31) (0,10) 
fdi -1.44*** -1.32*** -0,52*** -1.56*** -1.30*** -0,54*** 
 
(0.43) (0.34) (0,09) (0.43) (0.35) (0,09) 
Constant -1.65*** -1.51***  -1.64*** -1.53***  
 
(0.53) (0.50)  (0.53) (0.49)  
Observations  112     
Log Likelihood Full -114.7  -112.9  
Wald test full model (16)61.0***  (16)60.3***  
ρ 0.61  0.65  
Wald Test for ρ=0 (1)13.6820***  (1)15.1764***  
Notes: Robust standard errors in parentheses; ***, **, * denote significance at the 1%, 5% and 10% levels, 
respectively; degrees of freedom for X2 test in square brackets; Mg.Effect: Marginal effects.  
Source: Author 
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Annex 1: Variables included in the analysis, by adoption of joint learning strategies1 
Variable Freq. Mean S.D. Description 
train04 0=0; 1=55 1 -- 1 if the firm provided training to its employees in 2004; 0 otherwise. 
tr_internal 0=8; 1=47 0.85 -- 1 if training is provided by colleagues in-house; 0 otherwise 
external_tr 0=6; 1=49 0.89 -- 1 if the firm provides training through external providers (public 
universities, private universities, other firms, consultants or the 
industry’s trade organization); 0 otherwise. 
Internal_external
_tr 
1=6; 2=8; 
3=41 
2.64 0.68 1 if the firm provides internal training; 2 if the firm provides external 
training; 3 if the firm provides both internal and external training; 0 
otherwise. 
training_pubuniv 0= ;1=   1 if external training was provided by a public university; 0 otherwise 
training_priuniv 0= ;1=   1 if external training was provided by a private university; 0 otherwise 
training_firm 0= ;1=   1 if external training was provided by another firm; 0 otherwise 
training_tradeorg 0= ;1=   1 if external training was provided by a training centre linked to a 
trade organization; 0 otherwise 
training_freelance 0= ;1=   1 if external training was provided by an individual consultant; 0 
otherwise 
training_sup_mach 0= ;1=   1 if external training was provided by a supplier of machinery & 
equipment; 0 otherwise 
imp_empowerme
nt 
0=29; 1=20; 
2=6 
0.58 0.68 1 if the firm incorporates workers in decision-making but the practice 
is not important; 2 if the practice is important; 0 if workers do not take 
part in decision-making 
union 0=; 1=   1 If the firm reports a labour union in-house; 0 otherwise 
use_empower 0=29; 1=26 0.47 0.50 1 if the firm incorporates workers in decision-making; 0 otherwise 
pow_union 0=36; 1=19 0.34 0.48 1 If the firm incorporates workers in decision-making and there is a 
labour union in-house; 0 otherwise.  
rem_size -- 6.98 2.81 Average remuneration per worker representing total remuneration 
(salaries and benefits) paid in 2004 by average total employment 
during the same year. Variable normalized by applying a natural 
logarithm transformation2 and expressed in terms of a firm’s size.  
avgwage_size -- 6.51 2.67 Average salaries per worker paid in 2004 by average total 
employment during the same year. Variable normalized by applying 
a natural logarithm transformation2 and expressed in terms of a firm’s 
size. 
remhour_size -- 1.97 1.58 Average remuneration per hour paid in 2004. Variable normalized by 
applying a natural logarithm transformation2 and expressed in terms 
of a firm’s size. 
wagehour_size -- 1.50 1.51 Average salaries per hour paid in 2004. Variable normalized by 
applying a natural logarithm transformation2 and expressed in terms 
of a firm’s size. 
use_rotation 0=26; 1=29 0.53 -- 1 if the firm uses employee rotation assignments; 0 otherwise 
use_rotation_impo
rt 
0=26; 1=5; 
2=24 
0.96 0.96 1 if the firm uses employee rotation but the practice is not important; 
2 if the practice is important; 0 if workers do not take part in rotation 
assignments 
rule_temprotation 0=27; 1=28 0.51 -- 1 if the firm governs temporary employee rotation assignments 
(Regulation is through collective contract or other internal 
negotiations); 0 otherwise 
temp_rot_cc 0=44; 1=11 0.20 -- 1 if the firm reports that it governs rotation assignments for 
employees through collective contracts. 0 otherwise. 
temp_rot_ir 0=34; 1=21 0.38 -- 1 if the firm reports an internal regulation, other than collective 
contracts, to govern temporary rotation assignments for employees. 
0 otherwise 
rule_hiring 0=25; 1=30 0.54 -- 1 if the firm governs staff hiring for permanent positions through 
collective contract or other internal procedures. 0 otherwise 
hire_permwork_cc  0=42; 1=13 0.24 -- 1 if the firm governs staff hiring for permanent positions through 
collective contracts. 0 otherwise 
hire_permwork_ir 0=34; 1=21 0.38 -- 1 if the firm governs staff hiring for permanent position through 
internal regulations. 0 otherwise 
modern_practice 0=12; 1=43 0.78 -- 1 if the firm reports the use of TQM and/or JIT practices; 0 otherwise 
export_dummy 0=23; 1=32 0.58 -- Firms classified by exporting behaviour  
fdi 0=42; 1=13 0.24 -- Firms classified by foreign ownership: 0= Domestic, 1=foreign 
size_firm 1=66; 2=46 1.44 0.50 Size of the firm as defined by total employment; 1=small and 
medium sized (SME), 2=large 
Notes: Variables in bold are those created by the authors based on the information from ENESTYC, 2005; 1. Firms in sample, 112. Difference 
denotes the number of firms adopting a single learning strategy; 2. The logarithmic transformation was calculated only for firms reporting 
employment and alaries. S.D. Standard deviation 
Source: Author 
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Annex 2: Correlation analysis of explanatory and control variables included in the analysis 
  1 2 3 4 5 6 7 8 9 10 11 12 
1 train04 1            
2 training_internal 0.66 1           
3 external_training 0.60 0.30 1          
4 avgwage_size 0.12 0.27 0.27 1         
5 remhour_size 0.14 0.21 0.22 0.82 1        
6 wagehour_size 0.13 0.19 0.21 0.79 0.99 1       
7 imp_empowerment 0.16 0.09 0.11 0.13 0.02 0.02 1      
8 use_empower 0.15 0.05 0.11 0.05 -0.03 -0.03 0.91 1     
9 pow_union 0.20 0.15 0.19 0.12 0.09 0.09 0.72 0.75 1    
10 use_rotation 0.20 0.08 0.16 -0.02 0.00 0.02 0.54 0.63 0.55 1   
11 use_rotation_import 0.18 0.06 0.13 -0.01 0.02 0.04 0.56 0.66 0.57 0.96 1  
12 temp_rot_cc 0.16 0.13 0.22 0.18 0.08 0.08 0.14 0.12 0.27 0.18 0.16 1 
13 temp_rot_ir 0.18 0.13 -0.04 -0.18 -0.14 -0.14 0.15 0.22 0.00 0.29 0.29 -0.02 
14 rule_temprotation 0.25 0.21 0.10 -0.01 -0.02 -0.03 0.24 0.27 0.15 0.37 0.36 0.52 
15 rule_hiring 0.16 0.15 0.09 0.13 0.02 0.01 0.00 0.04 0.03 0.10 0.14 0.17 
16 hire_permwork_cc 0.04 0.17 0.10 0.17 0.06 0.08 0.04 0.05 0.20 0.05 0.10 0.33 
17 hire_permwork_ir 0.18 0.08 0.04 -0.10 -0.15 -0.16 -0.07 -0.02 -0.13 0.06 0.07 -0.02 
18 modern_practice 0.25 0.14 0.12 -0.01 -0.06 -0.04 0.44 0.51 0.36 0.53 0.53 -0.07 
19 export_dummy 0.14 0.26 0.12 0.41 0.38 0.38 0.09 0.09 0.12 0.02 0.05 -0.03 
20 fdi 0.17 0.26 0.08 0.48 0.42 0.40 0.19 0.19 0.28 0.16 0.17 0.14 
21 training_firm 0.46 0.19 0.76 0.25 0.21 0.21 0.11 0.09 0.18 0.14 0.13 0.26 
22 training_freelance 0.35 0.26 0.37 0.13 0.07 0.08 0.14 0.15 0.17 0.20 0.19 0.23 
23 training_priuniv 0.19 0.23 0.31 0.38 0.40 0.38 0.05 -0.02 -0.01 0.03 0.08 0.09 
24 training_pubcent 0.16 0.24 0.26 0.14 0.12 0.11 0.06 0.09 0.12 0.06 0.06 0.16 
25 training_pubuniv 0.14 0.09 0.24 0.15 0.20 0.19 -0.07 -0.11 0.00 -0.07 -0.03 0.14 
26 training_sup_mach 0.37 0.42 0.40 0.11 0.06 0.06 0.16 0.11 0.26 0.15 0.20 0.26 
27 training_tradeorg 0.21 0.11 0.34 0.13 0.08 0.07 0.11 0.09 0.18 0.16 0.13 0.10 
 
 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 
13 1               
14 0.77 1              
15 0.46 0.48 1             
16 0.06 0.19 0.55 1            
17 0.51 0.38 0.73 -0.03 1           
18 0.12 0.10 0.13 0.09 0.08 1          
19 -0.09 -0.06 0.06 0.01 -0.01 0.15 1         
20 -0.09 0.05 0.02 0.07 -0.13 0.19 0.55 1        
21 0.05 0.20 0.09 0.13 0.01 0.10 0.11 0.11 1       
22 0.19 0.29 0.27 0.09 0.19 0.17 0.25 0.14 0.28 1      
23 -0.09 0.04 0.09 0.14 -0.05 0.01 0.33 0.19 0.23 0.24 1     
24 -0.01 0.07 0.14 0.11 0.20 0.07 0.04 -0.05 0.15 0.26 0.10 1    
25 -0.12 -0.01 0.07 0.04 0.05 0.02 0.23 0.11 0.26 0.20 0.52 0.22 1   
26 0.00 0.13 0.08 0.10 0.04 0.21 0.19 0.02 0.32 0.48 0.21 0.29 0.18 1  
27 -0.15 -0.12 -0.23 -0.06 -0.19 0.11 0.10 0.04 0.15 0.14 0.12 0.17 0.17 0.23 1 
Notes: Characters in bold indicate statistical significance at the 1 percent level 
Source: Author 
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